Intermittent Fasting for Metabolic Health
Key Questions
What are the key findings from the 2024 RCT on 16:8 intermittent fasting?
The 2024 RCT showed 16:8 intermittent fasting reduces weight by 4% and improves HbA1c and lipids in type 2 diabetes and obese individuals. It works via autophagy and mitochondrial benefits.
How does intermittent fasting benefit metabolic health in T2D and obesity?
Intermittent fasting like 16:8 cuts weight, HbA1c, and lipids in T2D and obese patients through autophagy and mitochondrial improvements. It supports overall metabolic health.
What is the natural path to GLP-1 benefits without drugs?
Mercola highlights a natural metabolic loop involving quercetin that mimics GLP-1 effects for satiety and blood sugar control. This is particularly beneficial for seniors and those with T2D.
2024 RCT 16:8 IF cuts weight 4%, HbA1c/lipids T2D/obese via autophagy/mito; Mercola natural GLP-1 via metabolic loop/quercetin echoes satiety/BS for seniors/T2D; cons include deficiencies/mortality risks esp short windows seniors; repetitive eating aids weight loss 5.9%.